AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 273: R1972-R1979, 1997;
0363-6119/97 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Matteo, R.
Right arrow Articles by May, C. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Matteo, R.
Right arrow Articles by May, C. N.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 273, Issue 6 1972-R1979, Copyright © 1997 by American Physiological Society

ARTICLES

Glucocorticoid-induced renal vasodilatation is mediated by a direct renal action involving nitric oxide

R. De Matteo and C. N. May
Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Parkville, Australia.

Glucocorticoids increase renal blood flow (RBF) and glomerular filtration rate, but the mechanisms are unclear. We investigated whether the cortisol-induced increment in RBF is a direct renal action or secondary to its systemic effects and whether nitric oxide (NO) plays a role in this response. In conscious sheep, cortisol infused intravenously (5.0 mg/h) or into the renal artery (1.3 mg/h) for 5 h increased RBF by 66 +/- 8 and 53 +/- 11 ml/min, respectively. Plasma glucose was increased by intravenous cortisol (0.4 +/- 0.1 mmol/l) but not by intrarenal cortisol. Renal vein plasma cortisol levels were similar at the end of each infusion (193 +/- 31 intravenously; 151 +/- 25 nmol/l intrarenal), but systemic levels were different (277 +/- 31 intravenous; 69 +/- 10 nmol/l intrarenal). Inhibition of NO synthesis by N omega-nitro-L-arginine infused intravenously (10 mg/kg followed by 5 mg.kg-1.h-1) or intrarenally (2 mg.kg-1.h-1) significantly reduced the cortisol-induced renal vasodilatation. In contrast, constriction of the renal vasculature with intrarenal angiotensin (0.3 microgram/h) did not prevent the cortisol-induced renal vasodilatation. These findings demonstrate that cortisol acts directly on the kidney to cause renal vasodilatation and to increase RBF and suggest that this response involves the endothelium-derived relaxing factor NO.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
N. A. Bobadilla, E. Tapia, F. Jimenez, L. G. Sanchez-Lozada, J. Santamaria, A. Monjardin, A. Bolio, G. Gamba, and J. Herrera-Acosta
Dexamethasone increases eNOS gene expression and prevents renal vasoconstriction induced by cyclosporin
Am J Physiol Renal Physiol, September 1, 1999; 277(3): F464 - F471.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. de Matteo and C. N. May
Inhibition of prostaglandin and nitric oxide synthesis prevents cortisol-induced renal vasodilatation in sheep
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1999; 276(4): R1125 - R1131.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Anwar, M. Schwab, L. Poston, and P. W. Nathanielsz
Betamethasone-mediated vascular dysfunction and changes in hematological profile in the ovine fetus
Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1137 - H1143.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online